About RhoGAM® Brand
RhoGAM® Brand was the first and is still the leading* Rho(D) immune globulin brand for the prevention of Rh hemolytic disease of the newborn (HDN).
Prior to the introduction of RhoGAM® Brand in 1968, HDN was a major cause of infant mortality, responsible for an average of 10,000 deaths annually in the United States.3 Since the introduction of Rh immune globulin products, like RhoGAM® Brand, the incidence of HDN has been virtually eliminated in most developed countries. RhoGAM® Brand is made by Ortho Clinical Diagnostics, a Johnson & Johnson company.
RhoGAM® BRAND
- Has a 40-year record of protecting millions of expectant mothers with no documented case of viral transmission
- Is from a Johnson & Johnson company—the people who have been caring for babies for more than a century
- Is the original and still the leading* treatment for HDN
*In the U.S. (Data on File)
The Science Behind the Miracle